Testing effectiveness (Phase 2)Ended earlyNCT01843452
What this trial is testing
Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal
Who this might be right for
Carcinoma of Anal Canal
Centre Hospitalier Universitaire Vaudois 8